Stocks in news: Dr Reddy's, ITC, TCS, BEL, Axis, BPCL, Disa, ITD

Here are stocks that are in news today:

Castrol India Q4-Net profit up 11.4 percent at Rs 155.8 crore versus Rs 139.8 crore (QoQ)-Total income up 2.7 percent at Rs 782.2 crore versus Rs 761.7 crore (QoQ)-EBITDA up 3.1 percent at Rs 219.5 crore versus Rs 212.9 crore (QoQ)-EBITDA margin at 28.1 percent versus 28 percent (QoQ)

Hind Aluminium Industries Q3-Net profit down 56 percent at Rs 1.1 crore versus Rs 2.5 crore (YoY)-Total income down 29.4 percent at Rs 102.8 crore versus Rs 145.7 crore (YoY)-EBITDA down 58.9 percent at Rs 3 crore versus Rs 7.3 crore (YoY)-EBITDA margin at 2.9 percent versus 5 percent (YoY)

Huhtamaki PPL Q3-Net profit down 25.7 percent at Rs 15.3 crore versus Rs 20.6 crore (YoY)-Total income down 1 percent at Rs 522.5 crore versus Rs 528 crore (YoY)-EBITDA down 18.4 percent at Rs 53.2 crore versus Rs 65.2 crore (YoY)-EBITDA margin at 10.2 percent versus 12.3 percent (YoY)

Elantas Beck Q3-Net profit up 20.6 percent at Rs 11.7 crore versus Rs 9.7 crore (YoY)-Total income up 0.2 percent at Rs 85.3 crore versus Rs 85.1 crore (YoY)-EBITDA up 5.8 percent at Rs 16.3 crore versus Rs 15.4 crore (YoY)-EBITDA margin at 19.1 percent versus 18.1 percent (YoY)

ITD Cementation Q3-Consolidated net profit down 56.8 percent at Rs 13 crore versus Rs 30.1 crore (YoY)-Consolidated total income down 31.3 percent at Rs 729.9 crore versus Rs 1,063.2 crore (YoY)-Consolidated EBITDA down 15.2 percent at Rs 55.6 crore versus Rs 65.6 crore (YoY)-Consolidated EBITDA margin at 7.6 percent versus 6.2 percent (YoY)-Consolidated tax expense at Rs 12.6 crore versus Rs 3.2 crore (YoY)

Bharat Electronics - Government official says-Government to sell 5 percent stake in Bharat Electronics (BEL) today and tomorrow-BEL stake sale floor price at Rs 1,498/share-Government may garner Rs 1,600 crore via BEL stake sale

Axis Bank - Finance ministry official says-Government not aware of any expression of interest to buy Axis Bank-No current plan to further sell stake in companies held under SUUTI

Dr Reddy's Labs says-US FDA completes inspection of Miryalaguda unit with 3 observations-Addressing observations made by US FDA

Other stocks and sectors that are in news today:-Aurobindo Pharma recalls of 47,040 bottles of Venlafaxine hydrochloride capsules (an anti-depressant)-Cadila Healthcare: Zydus gets US FDA approval for Clobetasol Propionate spray (used to treat various skin disorders)-Jagran Prakashan ex-date for buy back eligibility-Mastek - ICRA assigns rating of A+ and A1+-Gulf Oil Lubricants - CARE reaffirms rating of AA--IL&FS Engineering board meeting on February 27 to determine price of preferential issue to promoters-Power Grid gets letter of intent for 765kV Strengthening in Eastern region-IFCI to discontinue operations of regional offices at 5 locations by May 17, 2017-Castex Technologies & Metalyst Forgings board meeting on February 25 to consider issue of equity or equity-linked securities-Arfin India board meeting on February 24 to consider issue & allotment of equity on conversion of warrants-Eastern Gases board meeting on February 28 to consider acquiring 100 percent stake in Asia LPG, raise funds from banks, issue of equity / warrants to promoters-Tiger Logistics is winner of fastest growing logistics company of the year for Gujarat-Tata Chemicals' Haldia plant to be shut from February 21 to April 15 for ammonia pipline relocating project-Disa's parent company signs MoU with Auctus Fund to purchase 100 percent stake in Light Metal Casting solutions held by Auctus-Apollo Hospitals board meeting on February 23 to consider and allot non-convertible debentures (NCDs) worth Rs 200 crore-ONGC likely to pick up government’s stake in HPCL or BPCL for integrated drive: ET-Tata Motors, Volkswagen partnership talks in advanced stage; deal may have huge impact on India, emerging markets: ET-ITC to hike cigarette prices by up to 13 percent: Mint-JC penny to reduce outsourcing of software business to Infosys and TCS-M&M eyes threefold increase in commercial vehicle market share in 5 years-Ind RA maintains negative outlook on infra sector-FIPB defers Gland Pharma's acquisition by China’s Fosun; more consultations necessary: Sources